Literature DB >> 10901229

Alpha-synuclein inclusions in amygdala in the brains of patients with the parkinsonism-dementia complex of Guam.

M Yamazaki1, Y Arai, M Baba, T Iwatsubo, O Mori, Y Katayama, K Oyanagi.   

Abstract

We investigated by immunohistochemistry the deposition of alpha-synuclein in the brains of deceased patients with the parkinsonism-dementia complex (PDC) of Guam. Five of 13 PDC brains showed numerous alpha-synuclein positive neuronal inclusions and abnormal neurites, chiefly in the amygdala. Similar alpha-synuclein positive lesions were observed, although to a lesser extent, in the entorhinal cortex and the dorsal vagal nucleus. No alpha-synuclein positive inclusions were observed in motor cortex or locus coeruleus, and only a small number of positive inclusions were found in the Sommer's sector, temporal cortex, or substantia nigra. Some of the alpha-synuclein positive inclusions were reminiscent of cortical Lewy bodies (LB), but many of those in the amygdala coexisted with tau-positive pretangles and/or neurofibrillary tangles (NFT) within the same neurons. In these neurons, tau-positive shells encapsulated alpha-synuclein positive central cores or irregularly shaped alpha-synuclein-positive deposition intermingled with pretangles/NFT. Thus, the present study suggests that a common mechanism may govern aggregation of alpha-synuclein and tau in the amygdala, and that aggregation of alpha-synuclein may play some role in the neurodegenerative process of a tauopathy (i.e. PDC) in which Abeta deposition is virtually absent.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10901229     DOI: 10.1093/jnen/59.7.585

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  15 in total

Review 1.  Lewy bodies and dementia.

Authors:  D Galasko
Journal:  Curr Neurol Neurosci Rep       Date:  2001-09       Impact factor: 5.081

2.  Pathobiochemical effect of acylated steryl-β-glucoside on aggregation and cytotoxicity of α-synuclein.

Authors:  Seigo Usuki; Tetsu Kamitani; Yasuhiro Matsuo; Robert K Yu
Journal:  Neurochem Res       Date:  2011-11-29       Impact factor: 3.996

3.  Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of Parkinsonism-dementia complex of Guam but not Alzheimer's disease or progressive supranuclear palsy.

Authors:  Wan Yang; Randall L Woltjer; Izabela Sokal; Catherine Pan; Yan Wang; Mary Brodey; Elaine R Peskind; James B Leverenz; Jing Zhang; Daniel P Perl; Douglas R Galasko; Thomas J Montine
Journal:  Am J Pathol       Date:  2007-08-03       Impact factor: 4.307

Review 4.  Proteomics of human neurodegenerative diseases.

Authors:  Jing Zhang; C Dirk Keene; Catherine Pan; Kathleen S Montine; Thomas J Montine
Journal:  J Neuropathol Exp Neurol       Date:  2008-10       Impact factor: 3.685

5.  Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia.

Authors:  Jonathan Wills; Jessica Jones; Thomas Haggerty; Valeriy Duka; Jeffrey N Joyce; Anita Sidhu
Journal:  Exp Neurol       Date:  2010-06-28       Impact factor: 5.330

Review 6.  The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases.

Authors:  Peter T Nelson; Erin L Abner; Ela Patel; Sonya Anderson; Donna M Wilcock; Richard J Kryscio; Linda J Van Eldik; Gregory A Jicha; Zsombor Gal; Ruth S Nelson; Bela G Nelson; Jozsef Gal; Md Tofial Azam; David W Fardo; Matthew D Cykowski
Journal:  J Neuropathol Exp Neurol       Date:  2018-01-01       Impact factor: 3.685

7.  Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam.

Authors:  Mark S Forman; M Luise Schmidt; Sanjay Kasturi; Daniel P Perl; Virginia M-Y Lee; John Q Trojanowski
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

8.  Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease.

Authors:  W Michael Caudle; Sheng Pan; Min Shi; Thomas Quinn; Jake Hoekstra; Richard P Beyer; Thomas J Montine; Jing Zhang
Journal:  Proteomics Clin Appl       Date:  2008-09-10       Impact factor: 3.494

9.  Proteome response to the panneural expression of human wild-type alpha-synuclein: a Drosophila model of Parkinson's disease.

Authors:  Zhiyin Xun; Thomas C Kaufman; David E Clemmer
Journal:  J Proteome Res       Date:  2008-08-07       Impact factor: 4.466

Review 10.  Interactions of amyloidogenic proteins.

Authors:  Benoit I Giasson; Virginia M-Y Lee; John Q Trojanowski
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 4.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.